Rating date
Jun 2, 2026
69 days ago
Thermo Fisher Scientific (TMO) Stock Analysis
HOLDTMO Equity Research — HOLD — June 2026
Desk view
HOLD
5D move
-2.58%
Neutral (HOLD unscored)
Peer rank
89p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · TMO
Over the trailing year, TMO established a clear upward channel. The stock advanced from the $390s in June 2025 to the $470s–$480s range by April 2026, supported by consistent buying on pullbacks. The 200-day SMA (~$526) remained above pr...
Desk rating
HOLD
Tactical HOLD · 12M OW
Horizon
Tactical HOLD · 12M OVERWEIGHT
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
HOLD
Catalysts
- TMO is in a short-term recovery rally following an aggressive May correction, and the MACD bullish crossover adds weight to the near-term upside case.
- The 50-day SMA (~$480) has been reclaimed — this is a positive near-term signal, and the stock held this level as support in late May.
- The 200-day SMA (~$526) is the key battleground. A sustained break above it would negate the death cross and signal a resumption of the long-term uptrend.
Risks
- Event-driven repricing risk if expectations diverge from incoming evidence.
Market chart
Price context alongside the research narrative.
TMO Research Note
Full desk note for Jun 2, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
TMO Equity Research Note
TMO Stock Rating Summary
TMO bias
HOLD
Horizon
Tactical HOLD · 12M OVERWEIGHT
TMO key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
TMO catalyst watch
TMO is in a short-term recovery rally following an aggressive May correction, and the MACD bullish crossover adds weight to the near-term upside case.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
-2.58%Neutral (HOLD unscored)Peer 89pExpandCollapse
How the call aged · 5D
-2.58%Neutral (HOLD unscored)Peer 89p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-09T07:21:49.458456+00:00.
5D move
-2.58%
2026-06-02 → 2026-06-08
Outcome
Neutral (HOLD unscored)
5D trend
+7.56%
Vol (20D ann.)
+33.38%
vs SPY: +6.37%
Close 482.08 → — (USD, vendor closes)
Publish QC
passedExpandCollapse
Publish QC
passed
Pipeline fingerprint 781c0b04aa680fac
No QC issues recorded.